These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9490922)

  • 21. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttranslational truncation of E-cadherin and significance for tumour progression.
    Masterson J; O'Dea S
    Cells Tissues Organs; 2007; 185(1-3):175-9. PubMed ID: 17587823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New concepts of molecular biology for colon carcinogenesis.
    Kountouras J; Boura P; Lygidakis NJ
    Hepatogastroenterology; 2000; 47(35):1291-7. PubMed ID: 11100335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cadherin and catenin alterations in human cancer.
    Hajra KM; Fearon ER
    Genes Chromosomes Cancer; 2002 Jul; 34(3):255-68. PubMed ID: 12007186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
    Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
    Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Better understanding of the biology of cancer cells].
    Klein G
    Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biology of cancer invasion and metastasis.
    Mareel MM; Crombez R
    Acta Otorhinolaryngol Belg; 1992; 46(2):107-15. PubMed ID: 1605015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical prognostic markers in bladder cancer.
    Ioachim E; Stavropoulos NE; Charalabopoulos K; Agnantis NJ
    J BUON; 2002; 7(3):207-16. PubMed ID: 17918790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways.
    Noë V; Chastre E; Bruyneel E; Gespach C; Mareel M
    Biochem Soc Symp; 1999; 65():43-62. PubMed ID: 10320932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
    Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological perspectives].
    Pujol JL; Demoly P; Quantin X; Simony J; Parrat E; Lehmann M; Daurès JP; Jolimoy G; Grenier J; Pau B; Godard P
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):428-40. PubMed ID: 9690313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cancer metastasis].
    Berner A; Bryne M; Thrane PS
    Tidsskr Nor Laegeforen; 1996 Mar; 116(8):952-7. PubMed ID: 8650655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.